| Patent | Date |
|---|
Ketone inhibitors of lysine gingipain
Grant 11,325,884 - Konradi , et al. May 10, 2 | 2022-05-10 |
Aminopyridine Compounds And Methods For The Preparation And Use Thereof
App 20210340105 - Konradi; Andrei W. ; et al. | 2021-11-04 |
Aminopyridine compounds and methods for the preparation and use thereof
Grant 11,059,786 - Konradi , et al. July 13, 2 | 2021-07-13 |
Ketone Inhibitors Of Lysine Gingipain
App 20210053908 - Konradi; Andrei W. ; et al. | 2021-02-25 |
Ketone inhibitors of lysine gingipain
Grant 10,730,826 - Konradi , et al. | 2020-08-04 |
Aminopyridine Compounds And Methods For The Preparation And Use Thereof
App 20200148642 - Konradi; Andrei W. ; et al. | 2020-05-14 |
Ketone Inhibitors Of Lysine Gingipain
App 20190210960 - Konradi; Andrei W. ; et al. | 2019-07-11 |
Triazolopyridazine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereof
Grant 9,187,484 - Galemmo, Jr. , et al. November 17, 2 | 2015-11-17 |
Triazolopyridazine Compounds, Use As Inhibitors Of The Kinase Lrrk2, And Methods For Preparation Thereof
App 20130296298 - Galemmo, JR.; Robert A. ; et al. | 2013-11-07 |
Inhibitors of Polo-Like Kinase
App 20120115848 - Galemmo, JR.; Robert A. ; et al. | 2012-05-10 |
N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
Grant 7,795,440 - Ho , et al. September 14, 2 | 2010-09-14 |
N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
Grant 7,196,110 - Ho , et al. March 27, 2 | 2007-03-27 |
Inhibitors of factor Xa with a neutral P1 specificity group
Grant 6,602,895 - Galemmo, Jr. , et al. August 5, 2 | 2003-08-05 |
Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitors
Grant 6,548,525 - Galemmo, Jr. , et al. April 15, 2 | 2003-04-15 |
Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors
Grant 6,271,237 - Galemmo, Jr. , et al. August 7, 2 | 2001-08-07 |
Inhibitors of factor Xa with a neutral P1 specificity group
Grant 5,998,424 - Galemmo, Jr. , et al. December 7, 1 | 1999-12-07 |
Substituted naphthylene compounds exhibiting selective leukotriene B.sub.4 antagonist activity
Grant 5,468,898 - Huang , et al. November 21, 1 | 1995-11-21 |
Substituted monocyclic aryl compounds exhibiting selective leukotriene B.sub.4 antagonist activity
Grant 5,232,948 - Huang , et al. August 3, 1 | 1993-08-03 |
Disubstituted aryl compounds exhibiting selective leukotriene B4 antagonist activity
Grant 5,210,208 - Huang , et al. May 11, 1 | 1993-05-11 |
Quinoline derivatives and use thereof as antagonists of leukotriene D.sub.4
Grant 4,920,132 - Huang , et al. April 24, 1 | 1990-04-24 |
Quinoline derivatives and use thereof as antagonists of leukotriene D.sub.4
Grant 4,920,131 - Huang , et al. * April 24, 1 | 1990-04-24 |
Quinoline derivatives and use thereof as antagonists of leukotriene D.sub.4
Grant 4,920,133 - Huang , et al. April 24, 1 | 1990-04-24 |
Quinoline derivatives and use thereof as antagonists of leukotriene D.sub.4
Grant 4,920,130 - Huang , et al. April 24, 1 | 1990-04-24 |
Quinoline derivatives and use thereof as antagonists of leukotriene d4
Grant 4,918,081 - Huang , et al. April 17, 1 | 1990-04-17 |
| 